Treatment of Carbapenem-Resistant Multidrug-Resistant Gram-Negative Bacilli with Intracerebroventricular Injection of Polymyxin B: A Retrospective Study

References

• Mayhall CG, Archer NH, Lamb VA, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med. 1984;310(9):553–559. doi:10.1056/NEJM198403013100903
   PubMed Web of Science ®Google Scholar
• Schade RP, Schinkel J, Visser LG, Van Dijk JMC, Voormolen JHC, Kuijper EJ. Bacterial meningitis caused by the use of ventricular or lumbar cerebrospinal fluid catheters. J Neurosurg. 2005;102(2):229–234. doi:10.3171/jns.2005.102.2.0229
   PubMed Web of Science ®Google Scholar
• Schade R, Schinkel J, Roelandse F, et al. Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis. J Neurosurg. 2006;104:101–108. doi:10.3171/JNS.2006.104.1.101
   PubMed Web of Science ®Google Scholar
• Korinek AM, Baugnon T, Golmard JL, van Effenterre R, Coriat P, Puybasset L. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery. 2006;59(1):126–133;discussion 126–133. doi:10.1227/01.NEU.0000220477.47323.92
   Web of Science ®Google Scholar
• Kourbeti IS, Jacobs AV, Koslow M, Karabetsos D, Holzman RS. Risk factors associated with postcraniotomy meningitis. Neurosurgery. 2007;60(2):317–325;discussion 325–326. doi:10.1227/01.NEU.0000249266.26322.25
   Web of Science ®Google Scholar
• Metan G, Alp E, Aygen B, Sumerkan B. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother. 2007;60(1):197–199. doi:10.1093/jac/dkm181
   PubMed Web of Science ®Google Scholar
• Moon C, Kwak YG, Kim ES, Kim ES, Lee CS, Lee C-S. Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii. J Infect Chemother. 2013;19(5):916–919. doi:10.1007/s10156-013-0608-7
   PubMed Web of Science ®Google Scholar
• Rodríguez Guardado A, Blanco A, Asensi V, et al. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother. 2008;61(4):908–913. doi:10.1093/jac/dkn018
   PubMed Web of Science ®Google Scholar
• Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254–1263. doi:10.1086/529198
   PubMed Web of Science ®Google Scholar
• Murray CK, Hospenthal DR. Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis. 2005;18(6):502–506. doi:10.1097/01.qco.0000185985.64759.41
   Web of Science ®Google Scholar
• Wen DY, Bottini AG, Hall WA, Haines SJ. Infections in neurologic surgery. The intraventricular use of antibiotics. Neurosurg Clin N Am. 1992;3(2):343–354. doi:10.1016/S1042-3680(18)30666-1
   PubMedGoogle Scholar
• Mohapatra SS, Dwibedy SK, Padhy I. Polymyxins, the last-resort antibiotics: mode of action, resistance emergence, and potential solutions. J Biosci. 2021;46(3):85. doi:10.1007/s12038-021-00209-8
   PubMed Web of Science ®Google Scholar
• Ayoub Moubareck C et al. Polymyxins and bacterial membranes: a review of antibacterial activity and mechanisms of resistance. Membranes (Basel); 2020 10 8 181. doi:10.3390/membranes10080181.
   Web of Science ®Google Scholar
• Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006–09). J Antimicrob Chemother. 2011;66(9):2070–2074. doi:10.1093/jac/dkr239
   PubMed Web of Science ®Google Scholar
• Roberts KD, Azad MAK, Wang J, et al. Antimicrobial activity and toxicity of the major lipopeptide components of polymyxin B and colistin: last-line antibiotics against multidrug-resistant gram-negative bacteria. ACS Infect Dis. 2015;1(11):568–575. doi:10.1021/acsinfecdis.5b00085
   PubMed Web of Science ®Google Scholar
• López-Alvarez B, Martín-Láez R, Fariñas MC, Paternina-Vidal B, García-Palomo JD, Vázquez-Barquero A. Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin. Acta Neurochir. 2009;151(11):1465–1472. doi:10.1007/s00701-009-0382-6
   PubMed Web of Science ®Google Scholar
• Markantonis S, Markou N, Fousteri M, et al. Penetration of colistin into cerebrospinal fluid. Antimicrob Agents Chemother. 2009;53(11):4907–4910. doi:10.1128/AAC.00345-09
   PubMed Web of Science ®Google Scholar
• Ziaka M, Markantonis SL, Fousteri M. Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother. 2013;57(4):1938–1940. doi:10.1128/AAC.01461-12
   PubMed Web of Science ®Google Scholar
• Tunkel A, Hasbún R, Bhimraj A, et al. 2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64:701–706. doi:10.1093/cid/ciw861
   Web of Science ®Google Scholar
• Chusri S, Sakarunchai I, Kositpantawong N, et al. Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant Acinetobacter baumannii. Int J Antimicrob Agents. 2018;51(4):646–650. doi:10.1016/j.ijantimicag.2017.12.002
   PubMed Web of Science ®Google Scholar
• De Bonis P, Lofrese G, Scoppettuolo G, et al. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis. Eur J Neurol. 2016;23(1):68–75. doi:10.1111/ene.12789
   PubMed Web of Science ®Google Scholar
• Pan S, Huang X, Wang Y, et al. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinetobacter baumannii: a retrospective cohort study. Antimicrob Resist Infect Control. 2018;7(1):8. doi:10.1186/s13756-018-0305-5
   Web of Science ®Google Scholar
• Hu Y, He W, Yao D, Dai H. Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical intracranial infection due to multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a systematic review and meta-analysis. Int J Antimicrob Agents. 2019;54(5):556–561. doi:10.1016/j.ijantimicag.2019.08.002
   PubMed Web of Science ®Google Scholar
• Babiker A, Clarke LG, Saul M, et al. Changing epidemiology and decreased mortality associated with carbapenem-resistant gram-negative bacteria, 2000–2017. Clin Infect Dis. 2021;73(11):e4521–e4530. doi:10.1093/cid/ciaa1464
   PubMed Web of Science ®Google Scholar
• Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi:10.1186/s12941-017-0191-3
   PubMed Web of Science ®Google Scholar
• Lemos EV, de la Hoz FP, Einarson TR, et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect. 2014;20(5):416–423. doi:10.1111/1469-0691.12363
   PubMed Web of Science ®Google Scholar
• Karaiskos I, Galani L, Baziaka F, Giamarellou H. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents. 2013;41(6):499–508. doi:10.1016/j.ijantimicag.2013.02.006
   PubMed Web of Science ®Google Scholar
• Tsuji BT, Pogue JM, Zavascki AP, et al. International consensus guidelines for the optimal use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019;39(1):10–39. doi:10.1002/phar.2209
   PubMed Web of Science ®Google Scholar
• Fernandez-Viladrich P, Corbella X, Corral L, Tubau F, Mateu A. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis. 1999;28(4):916–917. doi:10.1086/517243
   PubMed Web of Science ®Google Scholar
• Tuon FF, Rocha JL, Arend LN, Wallbach K, Zanin HA, Pilonetto M. Treatment and outcome of nine cases of KPC-producing Klebsiella pneumoniae meningitis. J Infect. 2013;67(2):161–164. doi:10.1016/j.jinf.2013.04.003
   Web of Science ®Google Scholar
• Wang JH, Lin PC, Chou CH, et al. Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect. 2014;47(3):204–210. doi:10.1016/j.jmii.2012.08.028
   PubMedGoogle Scholar
• Shofty B, Neuberger A, Naffaa ME, et al. Intrathecal or intraventricular therapy for post-neurosurgical Gram-negative meningitis: matched cohort study. Clin Microbiol Infect. 2016;22(1):66–70. doi:10.1016/j.cmi.2015.09.023
   PubMed Web of Science ®Google Scholar
• Fotakopoulos G, Makris D, Chatzi M, Tsimitrea E, Zakynthinos E, Fountas K. Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin. Acta Neurochir. 2016;158(3):603–610;discussion 610. doi:10.1007/s00701-016-2702-y
   PubMed Web of Science ®Google Scholar
• Karvouniaris M, Brotis AG, Tsiamalou P, Fountas KN. The role of intraventricular antibiotics in the treatment of nosocomial ventriculitis/meningitis from gram-negative pathogens: a systematic review and meta-analysis. World Neurosurg. 2018;120:e637–e650. doi:10.1016/j.wneu.2018.08.138
   PubMed Web of Science ®Google Scholar
• Hoefnagel D, Dammers R, Laak-Poort MT, Avezaat C. Risk factors for infections related to external ventricular drainage. Acta Neurochirurgica. 2007. doi:10.1007/s00701-007-1458-9
   Web of Science ®Google Scholar
• Camacho E, Boszczowski Í, Basso M, et al. Infection rate and risk factors associated with infections related to external ventricular drain. Infection. 2010. doi:10.1007/s15010-010-0073-5
   Web of Science ®Google Scholar
• Xi-ling W Analysis of High Risk Factors of Intracranial Infection after Craniotomy in Neurosurgery Department. Journal of Beihua University. 2013.
   Google Scholar
• Stoodley P, Jr EEB, Nistico L, et al. Direct demonstration of Staphylococcus biofilm in an external ventricular drain in a patient with a history of recurrent ventriculoperitoneal shunt failure. Pediatr Neurosurg. 2010;46:127–132. doi:10.1159/000319396
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao R, Shi W, Zheng J, Li H, Li Z. Predictor of a permanent shunt after treatment of external ventricular draining in pediatric postinfective hydrocephalus—a retrospective cohort study. Childs Nervous Syst. 2021;37:1877–1882. doi:10.1007/s00381-021-05054-6
   Web of Science ®Google Scholar
• Sun C, Du H, Yin L, He M, Tian Y, Li H. Choice for the removal of bloody cerebrospinal fluid in postcoiling aneurysmal subarachnoid hemorrhage: external ventricular drainage or lumbar drainage? Turk Neurosurg. 2014;24(5):737–744. doi:10.5137/1019-5149.JTN.9837-13.2
   Web of Science ®Google Scholar
• Galea I. The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021;18(11):2489–2501. doi:10.1038/s41423-021-00757-x
   PubMed Web of Science ®Google Scholar
• Lebel MH, McCracken GH. Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics. 1989;83(2):161–167. doi:10.1542/peds.83.2.161
   PubMed Web of Science ®Google Scholar
• Khawcharoenporn T, Apisarnthanarak A, Mundy LM. Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review. Clin Microbiol Infect. 2010;16(7):888–894. doi:10.1111/j.1469-0691.2009.03019.x
   PubMed Web of Science ®Google Scholar
• Jamjoom AB, Mohammed AA, Al-Boukai A, Jamjoom ZA, Rahman N, Jamjoom HT. Multiloculated hydrocephalus related to cerebrospinal fluid shunt infection. Acta neurochir. 1996;138(6):714–719. doi:10.1007/BF01411477
   Web of Science ®Google Scholar
• Schultz P, Leeds NE. Intraventricular septations complicating neonatal meningitis. J Neurosurg. 1973;38(5):620–626. doi:10.3171/jns.1973.38.5.0620
   Web of Science ®Google Scholar
• Pandey S, Yao PW, Qian Z, Ji T, Wang K, Gao L. Clinical characteristics of hydrocephalus following the treatment of pyogenic ventriculitis caused by multi/extensive drug-resistant gram-negative bacilli, Acinetobacter baumannii, and Klebsiella pneumoniae. Front Surg. 2022;9:854627. doi:10.3389/fsurg.2022.854627
   Web of Science ®Google Scholar
• Mattos KPH, Cintra ML, Gouvêa IR, Ferreira LÁ, Velho PE, Moriel P. Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process. J Clin Pharm Ther. 2017;42(5):573–578. doi:10.1111/jcpt.12543
   PubMed Web of Science ®Google Scholar
• Tuthill RJ. Histologic diagnosis of inflammatory diseases of the skin. an algorithmic method based on pattern analysis, 3rd edition. Am J Surg Pathol. 2005;29(9):1264–1265. doi:10.1097/01.pas.0000174010.91697.1d
   Google Scholar
• Smith KR, Thiboutot DM. Thematic review series: skin lipids. Sebaceous gland lipids: friend or foe? J Lipid Res. 2008;49(2):271–281. doi:10.1194/jlr.R700015-JLR200
   PubMed Web of Science ®Google Scholar
• Nolano M, Provitera V, Caporaso G, et al. Cutaneous innervation of the human face as assessed by skin biopsy. J Anat. 2013;222(2):161–169. doi:10.1111/joa.12001
   PubMed Web of Science ®Google Scholar